Tilray (NASDAQ:TLRY) Shares Down 2.5%

Tilray Inc (NASDAQ:TLRY) shares fell 2.5% on Friday . The company traded as low as $1.73 and last traded at $1.74. 4,581,489 shares traded hands during trading, a decline of 82% from the average session volume of 24,963,607 shares. The stock had previously closed at $1.78.

Tilray Price Performance

The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The company’s 50 day moving average is $1.82 and its 200-day moving average is $1.87. The stock has a market cap of $1.45 billion, a PE ratio of -3.94 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last released its quarterly earnings results on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. During the same quarter last year, the firm posted ($0.15) EPS. The company’s revenue was up 24.8% compared to the same quarter last year. As a group, sell-side analysts predict that Tilray Inc will post -0.16 earnings per share for the current year.

Institutional Investors Weigh In On Tilray

Several hedge funds and other institutional investors have recently modified their holdings of TLRY. Chesapeake Capital Corp IL bought a new position in Tilray during the fourth quarter worth $55,000. RPO LLC bought a new stake in Tilray during the 4th quarter valued at $28,000. TD Asset Management Inc boosted its position in Tilray by 3.2% during the 4th quarter. TD Asset Management Inc now owns 1,242,538 shares of the company’s stock worth $2,883,000 after acquiring an additional 38,104 shares during the period. CIBC Asset Management Inc boosted its position in Tilray by 3.7% during the 4th quarter. CIBC Asset Management Inc now owns 672,586 shares of the company’s stock worth $1,558,000 after acquiring an additional 23,786 shares during the period. Finally, Wellington Wealth Strategies LLC. bought a new position in shares of Tilray in the fourth quarter worth $29,000. Institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.